Liesbeth Keldermans

639 total citations
17 papers, 363 citations indexed

About

Liesbeth Keldermans is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Liesbeth Keldermans has authored 17 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Organic Chemistry. Recurrent topics in Liesbeth Keldermans's work include Glycosylation and Glycoproteins Research (12 papers), Genomics and Rare Diseases (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Liesbeth Keldermans is often cited by papers focused on Glycosylation and Glycoproteins Research (12 papers), Genomics and Rare Diseases (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Liesbeth Keldermans collaborates with scholars based in Belgium, Italy and France. Liesbeth Keldermans's co-authors include Gert Matthijs, Els Schollen, Jaak Jaeken, Christian Körner, Valérie Race, François Foulquier, Stephanie Grünewald, Daisy Rymen, Carlo Dionisi‐Vici and Luisa Sturiale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Human Molecular Genetics.

In The Last Decade

Liesbeth Keldermans

17 papers receiving 361 citations

Peers

Countries citing papers authored by Liesbeth Keldermans

Since Specialization

Citations

This map shows the geographic impact of Liesbeth Keldermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Keldermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Keldermans more than expected).

Fields of papers citing papers by Liesbeth Keldermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liesbeth Keldermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Keldermans. The network helps show where Liesbeth Keldermans may publish in the future.

Co-authorship network of co-authors of Liesbeth Keldermans

This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth Keldermans. A scholar is included among the top collaborators of Liesbeth Keldermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth Keldermans. Liesbeth Keldermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	COG6‐CDG: Novel variants and novel malformation 2022 ·Birth Defects Research ·(unknown), Paolo Bianchi, Luisa Sturiale, Domenico Garozzo, Giovanna Mangili, Liesbeth Keldermans, Renata Rizzo, Gert Matthijs, Agata Fiumara, Jaak Jaeken, Rita Barone	4
2	CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking 2022 ·Human Molecular Genetics ·Matthew P. Wilson, (unknown), Özlem Ünal, Bobby G. Ng, (unknown), Liesbeth Keldermans, Erika Souche, Daisy Rymen, Kemal Gündüz, Gülşen Köse, Luisa Sturiale, Domenico Garozzo, Hudson H. Freeze, Jaak Jaeken, François Foulquier, Gert Matthijs	9
3	RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement 2021 ·European Journal of Neurology ·(unknown), Matthieu Moisse, Valérie Race, (unknown), Liesbeth Keldermans, Sascha Vermeer, Hilde Van Esch, Kristl G. Claeys, Philip Van Damme	6
4	SLC35A2-CDG: Novel variant and review 2021 ·Molecular Genetics and Metabolism Reports ·Dulce Quelhas, (unknown), Jaak Jaeken, Luı́sa Azevedo, Mónica Lopes‐Marques, Anabela Bandeira, Liesbeth Keldermans, Gert Matthijs, Luisa Sturiale, Esmeralda Martins	21
5	SLC37A4‐CDG: Second patient 2021 ·JIMD Reports ·Matthew P. Wilson, Dulce Quelhas, Elisa Leão Teles, Luisa Sturiale, Daisy Rymen, Liesbeth Keldermans, Valérie Race, Erika Souche, Esmeralda Rodrigues, (unknown), Emile Van Schaftingen, François Foulquier, Domenico Garozzo, Gert Matthijs, Jaak Jaeken	7
6	MAN1B1-CDG: novel patients and novel variant 2021 ·Journal of Pediatric Endocrinology and Metabolism ·Çiğdem Seher Kasapkara, (unknown), Mustafa Kılıç, Liesbeth Keldermans, Gert Matthijs, Jaak Jaeken	5
7	Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype 2019 ·Proceedings of the National Academy of Sciences ·Eline Blommaert, Romain Péanne, Н. А. Черепанова, Daisy Rymen, Frederik Staels, Jaak Jaeken, Valérie Race, Liesbeth Keldermans, Erika Souche, Anniek Corveleyn, Rebecca Sparkes, Kaustuv Bhattacharya, Christine Devalck, Rik Schrijvers, François Foulquier, Reid Gilmore, Gert Matthijs	61
8	Challenges in molecular diagnosis of X-linked Intellectual disability 2019 ·British Medical Bulletin ·(unknown), Valérie Race, Liesbeth Keldermans, Marijke Bauters, Hilde Van Esch	13
9	Galactose Epimerase Deficiency: Expanding the Phenotype 2017 ·JIMD Reports ·(unknown), Sacha Ferdinandusse, (unknown), (unknown), Liesbeth Keldermans, Dulce Quelhas, Gert Matthijs, Petra A.W. Mooijer, Luísa Diogo, Jaak Jaeken, Paula Garcia	6
10	Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy 2016 ·Developmental Medicine & Child Neurology ·Carmen Barba, Francesca Darra, Raffaella Cusmai, (unknown), Carlo Dionisi‐Vici, Liesbeth Keldermans, Sandrine Vuillaumier‐Barrot, Dirk J. Lefeber, Renzo Guerrini, (unknown)	30
11	ALG8-CDG: novel patients and review of the literature 2015 ·Orphanet Journal of Rare Diseases ·(unknown), (unknown), Elisabeth Ralser, Ursula Kiechl‐Kohlendorfer, Sabine Scholl‐Bürgi, Christine Fauth, Elisabeth Steichen, Karin Pichler, Dirk J. Lefeber, (unknown), Liesbeth Keldermans, Kathrin Maurer, Johannes Zschocke, Daniela Karall	34
12	COG5-CDG: expanding the clinical spectrum 2012 ·Orphanet Journal of Rare Diseases ·Daisy Rymen, Liesbeth Keldermans, Valérie Race, Luc Régal, Nicolas Deconinck, Carlo Dionisi‐Vici, Cheuk Wing Fung, Luisa Sturiale, Claire Rosnoblet, François Foulquier, Gert Matthijs, Jaak Jaeken	33
13	Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient 2009 ·Glycobiology ·(unknown), Liesbeth Keldermans, J. Jaeken, (unknown), (unknown), Gert Matthijs, François Foulquier	19
14	Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients 2007 ·Molecular Genetics and Metabolism ·Els Schollen, Liesbeth Keldermans, François Foulquier, Paz Briones, Amparo Chabás, Félix Sánchez‐Valverde, Maciej Adamowicz, Ewa Pronicka, Ron A. Wevers, Gert Matthijs	34
15	The Normal Phenotype of Pmm1-Deficient Mice Suggests that Pmm1 Is Not Essential for Normal Mouse Development 2006 ·Molecular and Cellular Biology ·(unknown), (unknown), (unknown), Els Schollen, Liesbeth Keldermans, Raf Sciot, Rudi D’Hooge, P.P. De Deyn, Kurt Von Figura, Dieter Hartmann, Christian Körner, Gert Matthijs	28
16	Tissue distribution of the murine phosphomannomutases Pmm1 and Pmm2 during brain development 2005 ·European Journal of Neuroscience ·(unknown), Liesbeth Keldermans, An Snellinx, Jean‐François Collet, Stephanie Grünewald, Natalie De Geest, Raf Sciot, (unknown), Jaak Jaeken, Gert Matthijs, Dieter Hartmann	10
17	CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter) 2005 ·European Journal of Medical Genetics ·Els Schollen, Stephanie Grünewald, Liesbeth Keldermans, (unknown), Christian Körner, Gert Matthijs	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact